Home DIOSynVax

DIOSynVax

In operation
-
Vaccine Antigen Design Solution Provider
Basic
Enterprise Profile

Basic Information

DIOSynVax Custom Vaccine Antigen Design to Maximize Protection Against Existing and Future Viruses Globally. Based on viral structure and evolution, our patented approach combines computational biology with in vitro and in vivo validation to select optimal Vaccine Antigen Payload (VAP) candidates, while continuously expanding the database and improving our design.
DIOSynVax
Cambridge,England,United Kingdom
15~50 people
January 01, 2017
media@diosvax.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Application Scenarios
Innovative Drugs Traditional Vaccines (Biological Products for Prevention)